Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationArticle Published on 2023-01-302023-06-11 Journal: Transplant International [Category] B형 간염, [키워드] economics hepatitis B Immunoglobulin (IgG) liver transplant Prophylaxis. [DOI] 10.3389/ti.2023.10954 PMC 바로가기
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant RecipientsArticle Published on 2022-11-012022-11-15 Journal: Clinical gastroenterology and hepatology : the off [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome anti-S anti-SARS-CoV-2 antibody Antibody Response Antibody titer cellular Cellular immune response coronavirus COVID-19 defined domain dose filtration first vaccination HCs healthy control humoral immune response Immunosuppression increase increase in investigated liver liver transplant liver transplant recipients LTR LTRs Lymphocyte count mRNA mRNA-based non-responders Odds ratio Patient Prospective Study RBD recipient responders response risk factor SARS-CoV-2 SARS-CoV-2 vaccination second vaccination Seroconversion seronegative seropositive spike-specific T-cell response T cells the median Third and Fourth SARS-CoV-2 Vaccination. Transplant vaccination Vaccinations [DOI] 10.1016/j.cgh.2022.06.028 PMC 바로가기
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipientsArticle Published on 2022-10-192022-11-15 Journal: Vaccine [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] age anti-spike antibody antibodies Antibody titer booster conducted COVID-19 COVID-19 vaccine detectable dose doses fourth dose had more humoral immune response IQR kidney transplant recipients liver transplant no statistical difference Organ transplant participant patients proportion receiving recipient recipients regimen retrospective SARS-CoV-2 SARS-CoV-2 vaccine significantly higher solid-organ transplant Solid-organ transplantation SOT tested third dose vaccination. Vaccine vaccine doses vaccine injection [DOI] 10.1016/j.vaccine.2022.08.065 PMC 바로가기
Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective studyArticle Published on 2022-10-132022-11-15 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome administration anti-RBD antibody BNT-162b2 ChAdOx1 vaccine coronavirus coronavirus disease COVID-19 diabetes disease dose doses Effect Efficacy first dose IgG Immunity vaccine Immunoglobulin Infection kidney kidney transplant liver liver transplant Liver transplant. Local no difference older patient Organ transplant Patient platform Primary outcome Prospective Study prospectively studied question recipient reduced resulting SARS-CoV-2 SARS-CoV-2 vaccination second dose secondary endpoint seroconversion rate shown side significantly solid organ transplant spread to systemic adverse event the RBD the spike protein the vaccine trials unresponsiveness vaccination Vaccine vaccine doses vaccine platform [DOI] 10.1186/s12879-022-07764-x PMC 바로가기
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical and molecular hepatology [Category] 진단, [키워드] 95% CI 95% confidence interval adverse event anti-spike antibody antibody chronic hepatitis Chronic Hepatitis B chronic liver disease cirrhosis CLD collected data coronavirus disease COVID-19 COVID-19 vaccine database disease dose etiology Fatty liver groups humoral Inactivated vaccine liver liver transplant Meta-analysis mRNA vaccine neutralizing antibody Non-alcoholic fatty liver disease observational study Patient patients performed ranged recipient recipients reported SARS-CoV-2 SARS-CoV-2. seroconversion rate T cell response vaccine doses vaccine immunogenicity vaccine platform [DOI] 10.3350/cmh.2022.0087 PMC 바로가기
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment managementReview article Published on 2022-10-012022-10-05 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, 치료법, 치료제, [키워드] acute respiratory syndrome addition aggravate Asymptomatic caused Characteristics chronic liver disease cirrhosis clinical clinical manifestation Complication Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 patient Critical death disease dysfunction Epidemic extrapulmonary organs Factors hepatic function Hepatocellular carcinoma hypoxia immune increased risk infection with SARS-CoV-2 inflammatory factor storms Injury liver Liver damage Liver disease liver enzyme Liver function Liver injury liver transplant Liver transplantation management mechanism nonalcoholic fatty liver pathophysiological mechanism Patient patients prevalent public health reperfusion Respiratory disease risk SARS-CoV-2 severe disease Stress Treatment Vaccine [DOI] 10.1016/j.biopha.2022.113568 [Article Type] Review article
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort진행중인 미코페놀레이트 치료는 만성 염증성 자가면역 질환 또는 간 이식 수혜자의 영향을 받는 환자에서 항-SARS-CoV-2 백신 반응을 손상시킵니다: RIVALSA 예상 코호트의 결과Observational Study Published on 2022-08-122022-09-11 Journal: Viruses [Category] SARS, 임상, 진단, 치료기술, [키워드] 95% CI administration Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 vaccination Antibody Response Antibody titers ARMS Arthritis Autoimmune Autoimmune disease Autoimmune diseases Autoimmune hepatitis calcineurin calcineurin inhibitors chronic cohort of patients Complete connective tissue disease Connective tissue diseases detectable develop Diagnosis dose dose reduction Effect effective Eligible patients enrolled evaluate evaluated example first dose healthy subjects hepatology identify IgG immunogenicity immunosuppressive immunosuppressive therapy Immunosuppressive treatment independent predictor independent predictors individual inhibitor liver liver transplant Liver transplantation MMF mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA vaccine mRNA-based Multivariate analysis mycophenolate mycophenolate. neoplasia Novara observational study organ other diseases overlapped Patient patients performed predictor Prevent Prospective prospective observational study receiving recipients rejection required response Result rheumatoid arthritis rheumatological SARS-COV-2 infection selected Seroconversion seroconversion failure spondyloarthritis subgroups of patient suffered Suspension Tertiary therapy transplantation transplants treated Treatment unit Univariate analysis university vaccinated individual vaccination Vaccine vaccine response Vasculitis [DOI] 10.3390/v14081766 PMC 바로가기 [Article Type] Observational Study
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipientsMycophenolate mofetil은 간 이식 수혜자의 SARS-CoV-2 백신 3회 투여에 대한 체액 반응을 감소시킵니다.Article Published on 2022-08-012022-09-11 Journal: Liver international : official journal of the Inte [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95%CI Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 vaccination antibody Antibody titre appear booster dose consultation decrease defined determine develop dose doses Efficacy enrolled Factor failure French Gender humoral Humoral response identify independent independent risk factor liver liver transplant male MMF mRNA mRNA vaccine mycophenolate mycophenolate mofetil mycophenolate mofetil. Patient patients Predictive receiving recipient recipients responders response rate response to vaccination responsiveness risk factor Risk factors SARS-CoV-2 SARS-CoV-2 vaccine Serious Adverse Events Seroconversion Serologic response solid organ solid organ transplant the patient the vaccine Treatment vaccination Vaccine [DOI] 10.1111/liv.15258 PMC 바로가기 [Article Type] Article
Successful liver transplantation for hepatitis B-related acute liver failure in a patient with active COVID-19활성 COVID-19 환자의 B형 간염 관련 급성 간부전에 대한 성공적인 간 이식Case Reports Published on 2022-08-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] B형 간염, COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute COVID-19 acute liver failure Administered anti-spike antibodies anti-spike antibody Antiviral antiviral therapy benefit can not candidate competing complex coronavirus coronavirus disease COVID-19 detectable Deterioration effective Evidence evidence of female Hepatitis hepatitis B hepatotoxicity highlight hospital discharge liver liver failure Liver function liver transplant Liver transplantation liver transplantation. management Mild monoclonal antibody nasopharyngeal omicron Patient paucity of data PCR potential risk presenting progression recipient SARS-CoV-2 secondary to significantly the patient Transplant transplantation while with COVID-19 [DOI] 10.1111/tid.13889 PMC 바로가기 [Article Type] Case Reports
SARS-CoV-2 RNA detection in Formalin-Fixed Paraffin-Embedded (FFPE) tissue by droplet digital PCR (ddPCR)물방울 디지털 PCR(ddPCR)에 의한 포르말린 고정 파라핀 포매(FFPE) 조직에서 SARS-CoV-2 RNA 검출Article Published on 2022-07-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] COVID19(2023년), SARS, 치료기술, 치료법, 치료제, [키워드] amplified Atypical Bio-rad cause clinical utility clinically COVID-19 digital PCR droplet droplet digital PCR extraction fetal FFPE formalin formalin-fixed paraffin-embedded highest Infection limit of detection liver liver transplant liver transplant rejection material paraffin Placenta Placental viral infection positive positive sample Pregnancy qualitative test quantified rejection reported Respiratory disease reverse transcription RNA virus RPP30 SARS-CoV-2 SARS-CoV-2 nucleocapsid SARS-CoV-2 RNA detection sequence specimen specimens tested tissue Tissue-based viral detection total RNA transplant rejection Viral detection Viral detection in FFPE. viral infection [DOI] 10.1016/j.cca.2022.05.007 PMC 바로가기 [Article Type] Article